Lily D. Lu

发表

Animal Models of Systemic Lupus Erythematosus (SLE) and Ex Vivo Assay Design for Drug Discovery

M. Seavey, Lily D. Lu, K. Stump, 2011, Current protocols in pharmacology.

Depletion of Autoreactive Plasma Cells and Treatment of Lupus Nephritis in Mice Using CEP-33779, a Novel, Orally Active, Selective Inhibitor of JAK2

Jennifer L. Mason, P. Dobrzanski, B. Ruggeri, 2011, The Journal of Immunology.

Depletion of Autoreactive Plasma Cells and Treatment of Lupus Nephritis in Mice Using CEP-33779, a Novel, Orally Active, Selective Inhibitor of JAK2

Jennifer L. Mason, P. Dobrzanski, B. Ruggeri, 2011, The Journal of Immunology.

Novel, orally active, proteasome inhibitor, delanzomib (CEP-18770), ameliorates disease symptoms and glomerulonephritis in two preclinical mouse models of SLE.

B. Ruggeri, M. Seavey, Lily D. Lu, 2012, International immunopharmacology.

Inhibitor of JAK2 CEP-33779, a Novel, Orally Active, Selective Treatment of Lupus Nephritis in Mice Using Depletion of Autoreactive Plasma Cells and

Mason, B. Ruggeri, D. Gingrich, 2011 .

Novel Method of Monitoring Trace Cytokines and Activated STAT Molecules in the Paws of Arthritic Mice using Multiplex Bead Technology

M. Seavey, Lily D. Lu, K. Stump, 2010, BMC Immunology.

A highly selective, orally active inhibitor of Janus kinase 2, CEP-33779, ablates disease in two mouse models of rheumatoid arthritis

P. Dobrzanski, B. Ruggeri, D. Gingrich, 2011, Arthritis research & therapy.

Discovery of 7-arylsulfonyl-1,2,3,4, 4a,9a-hexahydro-benzo[4,5]furo[2,3-c]pyridines: identification of a potent and selective 5-HT₆ receptor antagonist showing activity in rat social recognition test.

Karla K Kopec, E. Duzic, E. Bacon, 2012, Bioorganic & medicinal chemistry letters.

Dimebolin is a 5-HT6 antagonist with acute cognition enhancing activities.

Michael J Marino, Jie Qian, J. Qian, 2009, Biochemical pharmacology.

Novel brain penetrant benzofuropiperidine 5-HT₆ receptor antagonists.

Karla K Kopec, E. Duzic, E. Bacon, 2012, Bioorganic & medicinal chemistry letters.

The Natural Stilbenoid (–)-Hopeaphenol Inhibits Cellular Entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7, and B.1.351 Variants

L. Montaner, I. Tietjen, H. Ertl, 2021, bioRxiv.

Therapeutic Efficacy of CEP-33779, a Novel Selective JAK2 Inhibitor, in a Mouse Model of Colitis-Induced Colorectal Cancer

P. Dobrzanski, B. Ruggeri, M. Seavey, 2012, Molecular Cancer Therapeutics.